Fast Growth In Russian OTC Market

20 January 1997

Russia's self-medication market is developing fast, with sales growingin excess of 30% per annum, according to a report from Nicholas Hall & Co, entitled OTC Opportunities in Emerging Markets: Former Soviet Union.

Multinationals which already have a strong presence in the sector include Warner-Lambert, Procter & Gamble and Johnson & Johnson. Looking at individual product sectors, it notes particularly strong growth in cough/cold and analgesic products, which totaled sales of $300 million in 1995, 75% of which was sold without prescription.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight